CIK 0001367083
- Non-accelerated filer
- Smaller reporting company
Sonoma Pharmaceuticals, Inc.
Sign in to watch- Ticker
- SNOA
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680423298
- Phone
- +1 800-759-9305
- Business address
- 5445 CONESTOGA COURT, SUITE 150, BOULDER, CO, 80301
- Former names
- Oculus Innovative Sciences, Inc.
- 4 Grant or award Director acquired 25,817 shares (grant or award)
- 4 Grant or award Director acquired 17,211 shares (grant or award)
- 4 Open-market buy Chief Executive Officer bought 345 shares at $4.95 ($1,708)
- 4 Grant or award Director acquired 14,317 shares (grant or award)
- 4 Grant or award Director acquired 14,130 shares (grant or award)
- 4 Grant or award Director acquired 13,757 shares (grant or award)
- 4 Grant or award Director acquired 13,944 shares (grant or award)
- 4 Open-market buy Chief Financial Officer bought 1,790 shares at an average $5.02 ($8,991)
- 4 Open-market buy Chief Executive Officer bought 400 shares at $5.03 ($2,012)
- 4 Open-market buy Chief Executive Officer bought 254 shares at $5.05 ($1,283)
- 4 Open-market buy Chief Financial Officer bought 2,000 shares at an average $5.03 ($10,065)
- 4 Grant or award Director acquired 1,210 shares (grant or award)
- 4 Grant or award Director acquired 1,045 shares (grant or award)
- 4 Grant or award Director acquired 715 shares (grant or award)
- 4 Grant or award Director acquired 880 shares (grant or award)
- 4 Open-market buy Chief Financial Officer bought 2,264 shares at $5.30 ($11,999)
- 4 Open-market buy Chief Strategy/Mkt Officer bought 600 shares at $5.31 ($3,186)
- 4 Open-market buy Chief Executive Officer bought 929 shares at $5.46 ($5,069)
- 4 Grant or award Chief Strategy/Mkt Officer acquired 2,042 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 2,406 shares (grant or award)
Page 5 of 16 · 317 filings